title: Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern?
authors.forename: J
authors.initials: J
authors.lastname: Amin
authors.forename: P B
authors.initials: PB
authors.lastname: McIntyre
authors.forename: T C
authors.initials: TC
authors.lastname: Heath
mesh_terms: D001315:Australia / Q000453:epidemiology; D002170:Canada / Q000453:epidemiology; D002648:Child; D002658:Developmental Disabilities / Q000453:epidemiology* / Q000209:etiology*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000453:epidemiology* / Q000209:etiology*; D008458:Measles Vaccine / Q000009:adverse effects*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000009:adverse effects*; D012411:Rubella Vaccine / Q000009:adverse effects*; D006113:United Kingdom / Q000453:epidemiology; D017778:Vaccines, Combined / Q000009:adverse effects
chemical_list: D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D017778:Vaccines, Combined